NTF-3, a gene involved in the enteric nervous system development, as a candidate gene for Hirschsprung disease

Journal of Pediatric Surgery

Volumn 43, Issue 7, 2008, Pages 1308-1311

  Ruiz Ferrer, Macarena ^a,b   Fernandez, Raquel M ^a,b   Antiñolo, Guillermo ^a,b   Lopez Alonso, Manuel ^a,b   Borrego, Salud ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

dHPLC; Germline mutation; Haplotype; Hirschsprung; Neurotrophins

Indexed keywords

NEUROTROPHIN 3 RECEPTOR;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HIRSCHSPRUNG DISEASE; HUMAN; INTESTINE INNERVATION; MAJOR CLINICAL STUDY; MALE; NERVOUS SYSTEM DEVELOPMENT; NEURAL CREST CELL; NTF 3 GENE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

EID: 47249114782     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2008.02.076     Document Type: Article

References (14)

1. Badner J.A., Sieber W.K., Garver K.L., et al. A genetic study of Hirschsprung disease. Am J Hum Genet 46 (1990) 568-580
2. Chakravarti A., and Lyonnet S. Hirschsprung disease. In: Scriver C.S., et al. (Ed). The metabolic and molecular bases of inherited disease (2002), McGraw-Hill, New York 6231-6255
3. Ruiz-Ferrer M., Fernandez R.M., Antiñolo G., et al. A complex additive model of inheritance for HSCR is supported by both RET mutations and predisposing RET haplotypes. Genet Med 8 (2006) 704-710
4. Fernandez R.M., Boru G., Pecina A., et al. Ancestral RET haplotype associated with Hirschsprung's disease shows linkage disequilibrium breakpoint at -1249. J Med Genet 42 (2005) 322-327
5. Griseri P., Bachetti T., Puppo F., et al. A common haplotype at the 5¢ end of the RET proto-oncogene, overrepresented in Hirschsprung patients, is associated with reduced gene expression. Hum Mutat 25 (2005) 189-195
6. Garcia-Barcelo M., Ganster R.W., Lui V.C., et al. TTF-1 and RET promoter SNPs: regulation of RET transcription in Hirschsprung's disease. Hum Mol Genet 14 (2005) 191-204
7. Burzynski G.M., Nolte I.M., Bronda A., et al. Identifying candidate Hirschsprung disease-associated RET variants. Am J Hum Genet 76 (2005) 850-858
8. Pelet A., de Pontual L., Clement-Ziza M., et al. Homozygosity for a frequent and weakly penetrant predisposing allele at the RET locus in sporadic Hirschsprung disease. J Med Genet 42 (2005) e18
9. Chalazonitis A. Neurotrophin-3 in the development of enteric nervous system. Prog Brain Res 146 (2004) 246-263
10. Hoehner J.C., Wester T., Pahlman S., et al. Alterations in neurotrophin and neurotrophin-receptor localization in Hirschsprung's disease. J Pediatr Surg 31 (1996) 1524-1529
11. In: Dracapoli N.H., Haines J.L., and Korf B.R. (Eds). Current protocols in human genetics (1994), John Wiley & Sons, New York
12. Edwards R.H., Selby M.J., Mobley W.C., et al. Processing and secretion of nerve growth factor: expression in mammalian cells with a vaccinia virus vector. Mol Cell Biol 8 (1998) 2456-2464
13. Suter U., Heymach Jr. J.V., and Shooter E.M. Two conserved domains in the NGF propeptide are necessary and sufficient for the biosynthesis of correctly processed and biologically active NGF. EMBO J 10 (1991) 2395-2400
14. Ng P.C., and Henikoff S. Predicting the effects of amino acid substitutions on protein function. Annu Rev Genomics Hum Genet 7 (2006) 61-80